Bioavailability Study of DP-R202 in Healthy Male Volunteers Under Fed Conditions

A Randomized, Single-dose, 2-sequence, 2-period Crossover Study to Investigate the Food-effect Pharmacokinetics of Sarpogrelate HCl Controlled Release Tablet in Healthy Male Subjects

A randomized, open-label, single-dose, crossover clinical trial to evaluate the food effect on the pharmacokinetics of DP-R202 tablet after oral administration in healthy male volunteers.

The number of patient is twenty-four.Patients were randomly assigned either DP-R202(Sarpogrelate HCL 300mg, qd) under fasting condition or DP-R202(Sarpogrelate HCL 300mg, qd) after eating foods.

Inclusion Criteria:

• 20 to 55 years of healthy volunteers

Exclusion Criteria:

• Hypersensitivity Reaction about Sarpogrelate HCL or other antiplatelets